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ABSTRACT 
Coronary heart disease is a prevalent issue in developed countries 
throughout the world. It can have crippling effects on the quality of life and even 
lead to mortality, in the case of myocardial infarction. Part of the problem is the 
lack of a robust regenerative response in mammals after injury. Zebrafish have 
an amazing ability to regenerate after injury, and studies have demonstrated that 
the regenerative response recapitulates embryonic development. Our lab 
previously reported the first analysis of coronary vessel development in zebrafish 
and demonstrated that coronary endothelial cells undergo angiogenesis to form a 
vascular network. The roles of perivascular cells in this process have not been 
examined in zebrafish. Using a transgenic reporter line marking pdgfrß 
expression, I found that pdgfrß is first observed in epicardium at the AV canal. At 
later stages of coronary vessel development, pdgfrß positive cells become 
localized to the perivascular region of mature vessels. I also observe that early in 
development, Tcf21 and pdgfrß co-express, which suggests a close relationship 
between the epicardium and pdgfrß+ cells. Previous findings from our lab 
revealed that cxcl12b+ cells localize to large coronary vessels during 
development. My findings reveal that pdgfrß+ marks perivascular cells of both 
capillaries and large coronary vessels. Lineage tracing analysis revealed that a 
subset of pdgfrß+ perivascular cells derive from tcf21 labeled epicardial cells. To 
see if disruption of Pdgfrß signaling impacts coronary development, I examined 
pdgfrß mutant hearts. In the Pdgfrß mutant, a mature coronary vessel network 
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fails to form, and instead we observe isolated endothelial cell islands. Lastly, I 
characterized a transgenic line that expresses a dominant negative form of 
Pdgfrß (dnpdgfrß) and can be potentially used for later developmental and/or 
regenerative studies. My findings indicate strong dnpdgfrß induction can be 
achieved at adult stages. My studies will greatly enhance our current 
understanding of coronary vessel development, and can be used as the basis for 
studying perivascular cells and their interactions with endothelial cells after 
cardiac injury in regeneration  
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CHAPTER ONE 
INTRODUCTION 
Background  
Coronary Heart Disease 
 
Coronary heart disease is a major concern for industrialized nations all 
over the world. Cardiovascular disease has deep implications on both human 
health and economics. According to the American Heart Association (AHA), in 
2011-2012 the sum of both direct and indirect costs of cardiovascular disease 
were 316.6 billion dollars. In 2013, coronary heart disease was responsible for 
approximately 1 in 7 deaths in the Unites States. Each year, an estimated 
660,000 Americans suffer a new coronary attack (defined as myocardial 
infarction) (Mozaffarian et al., 2015). Myocardial Infarction (MI), also known as a 
heart attack, is a common end result for people suffering from coronary heart 
disease. Myocardial Infarction results when cholesterols and other plaques 
accumulate over time and reduce or block blood flow in the coronary arteries. 
When blood flow is disrupted, proper oxygen and nutrient delivery to the 
remaining cardiac tissue is affected. When the tissues downstream of the 
blockage are deprived of oxygen, cardiac tissue will begin to be lost through the 
processes of apoptosis and necrosis (American Heart Association). Therefore, 
revascularization is one major therapeutic approach after myocardial infarction 
resulted from coronary heart disease. In addition to adult coronary disease, 
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congenital coronary artery anomalies can also be life threatening without surgical 
intervention. Despite the importance in both children and adults, the development 
of coronary vessels and revascularization after injury remain poorly understood. 
Zebrafish as a Model to Study Cardiovascular Development                                  
and Regeneration 
 
Zebrafish use as a model system was first established in the 1970’s by 
Streisinger and colleagues to study vertebrate development. Recently, the use of 
Zebrafish as a research model has seen a sharp increase due to the many 
advantages compared to other model organisms, such as mice. Zebrafish can be 
used to study human cardiac development disorder, since the genetic networks 
that regulate cardiac development are highly conserved (Fahed, Gelb, Seidman, 
& Seidman, 2013; Moorman & Christoffels, 2003). Due to the small size of 
zebrafish embryos, until the coronary vasculature forms, zebrafish can obtain 
their oxygen requirements through diffusion. This allows for the study of severe 
cardiovascular defects that might not be observable in other animal models, 
since the absence of a cardiovascular system leads to death (Bakkers, 2011; J. 
N. Chen et al., 1996; Sehnert et al., 2002; Stainier et al., 1996; Strecker, Seiler, 
Hollert, & Braunbeck, 2011). Zebrafish also have relatively large clutch sizes, 
which allows for greater statistical certainty. It is not uncommon for zebrafish 
pairs to lay hundreds of embryos per mating (Brown, Samsa, Qian, & Liu, 2016). 
Another advantage is the external development of the embryos which allows for 
easier embryo manipulation, as opposed to embryos in utero. Zebrafish embryos 
are optically transparent, which is a useful property in studying development. 
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Embryo clarity is useful to observe gene expression when researchers use 
whole-mount in situ hybridization and transgenic reporter lines for analyses. 
Zebrafish phenotyping and screening can be done using transgenic reporter 
lines, just by observation of the embryo live under fluorescence (Huang, Tu, 
Hsiao, Hsieh, & Tsai, 2003; Jin, Beis, Mitchell, Chen, & Stainier, 2005; Long et 
al., 1997; Perner, Englert, & Bollig, 2007). Lastly, zebrafish are amenable to 
other forward and reverse genetic approaches, which increase their usefulness in 
the lab. 
Zebrafish Heart 
Similar to all other vertebrates, the heart is the first organ to form during 
zebrafish development (Bakkers, 2011). The result of zebrafish cardiac 
development is a two-chambered heart, which is composed of one ventricle and 
one atrium. The atrium consists of a thin layer of muscle, whereas the ventricular 
myocardium consists of a thick outer compact layer and inner trabeculae layer 
(Hu, Yost, & Clark, 2001; Menke, Spitsbergen, Wolterbeek, & Woutersen, 2011; 
Poss, Wilson, & Keating, 2002). Incoming oxygenated blood flows from the 
atrium to the ventricle via the atrial-ventricular valve. At the base of the ventricle 
is a structure known as the bulbus arteriosus, which acts as the outflow tract so 
that the blood can reach the gill arches. Similar to mammals, the zebrafish heart 
is also composed of three tissue layers: epicardium, myocardium (compact and 
trabecular), and endocardium (Bakkers, 2011; Lien, Harrison, Tuan, & Starnes, 
2012). 
4 
 
Mammalian Coronary Vessel Development 
Although coronary vessel development is a crucial step in mammalian 
development, for decades the origin of these coronary vessels was unknown. 
Throughout the years, different theories were proposed to explain the origin of 
the coronary vasculature. Early anatomical studies proposed that the coronary 
arteries arose by budding from the aorta. Chick-quail chimaera studies proposed 
that proepicardial cells, which are progenitors of the epicardium, undergo 
epithelial-to-mesenchymal transition (EMT) to form the endothelial tubes, which 
will become the mature vessels (Hutchins, Kessler-Hanna, & Moore, 1988; 
Majesky, 2004). These widely held views were challenged when recent lineage 
tracing studies revealed that the proepicardium gave rise to few, if any coronary 
endothelial cells (Cai et al., 2008; Merki et al., 2005; Wilm, Ipenberg, Hastie, 
Burch, & Bader, 2005; Zhou et al., 2008). Recent work with mice, has revealed 
that the coronary vasculature is derived from existing endothelial cells that reside 
in the sinus venosus (SV). When examining the nascent plexus originating in the 
sinus venosus, vessels at this location expressed angiogenic sprout markers: 
Vegfr3, Dll4, and Pdgfrb (Hellstrom et al., 2007; Kidoya et al., 2008; Suchting et 
al., 2007; Tammela et al., 2008). More importantly, consistent with previous 
lineage racing results, the group did not observe proepicardial cells becoming 
endothelial cells (K. Red-Horse, H. Ueno, I. L. Weissman, & M. Krasnow, 2010). 
To test their model that the sinus venosus was required for coronary vessel 
development, they turned to an In Vitro culture system for help. In culture, hearts 
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with sinus venosus intact were compared to hearts with sinus venosus removed. 
Intact hearts developed coronary vessels, whereas dissected hearts displayed no 
coronary vessels. (K. Red-Horse, H. Ueno, I. L. Weissman, & M. A. Krasnow, 
2010). Clonal analysis demonstrated that most coronary arterial cells are clonally 
related to cells that reside in the sinus venosus, and that a single cell originating 
from the sinus venosus can give rise to the three coronary cell types: arteries, 
veins, and capillaries through reprogramming (K. Red-Horse et al., 2010). 
Follow-up studies supported the model that the sinus venosus contributes to 
coronary vasculature and also revealed that the endocardium can also give rise 
to regions of the coronary vasculature (Tian et al., 2013; Wu et al., 2012). 
Interestingly, the proepicardium was also shown to give rise to a uniform portion 
of vasculature around the heart. It was also observed that the dorsal coronary 
vasculature originates from the sinus venosus and is dependent on epicardial 
secreted VEGFC, which has been shown to activate endothelial cell migration. 
The importance of VEGFC to sinus venosus derived coronary vessels was 
demonstrated through VEGFC knockout mice. VEGFC knockout coronary 
vessels were wider and flatter, and contained fewer branch points, compared to 
wild type. The ventral coronary vasculature was shown to be derived from the 
endocardium and acts in a VEGFC independent manner (H. I. Chen et al., 2014). 
Ultimately, their model suggests that these two populations (Dorsal and Ventral), 
along with a minor contribution from the proepicardium, intermix to give rise to an 
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interconnected vasculature network during embryonic development (H. I. Chen et 
al., 2014) 
Zebrafish Coronary Vessel Development 
  Although studies in mice elucidated the source of coronary vessels in 
mammals, the origin of the coronary vasculature in zebrafish remained unclear. 
Our lab demonstrated that CXC chemokines play a major role in zebrafish 
coronary vessel development (Harrison et al., 2015). This was not surprising, 
since cxc chemokines have been shown to regulate cell adhesion and cell 
migration during development. CXCR4 and CXCL12 knockouts in mice display 
defects in cell migration (Raz & Mahabaleshwar, 2009). Zebrafish contain two 
cxcl12 genes, cxcl12a and cxcl12b, along with two receptors, cxcr4a and cxcr4b 
(Boldajipour et al., 2011). With the aid of transgenic lines that fluorescently tag 
endothelial cells, fli1a:EGFP, our lab discovered that the coronary vasculature 
does not form until 1-2 months post fertilization, a time point where other groups 
have demonstrated that the ventricular myocardium undergoes significant 
expansion. (Gupta & Poss, 2012; Harrison et al., 2015; Hu, Sedmera, Yost, & 
Clark, 2000). At 1-2 months post fertilization, endothelial cells emerge from the 
atrial-ventricular canal, a region between the atrium and ventricle that has direct 
connection to the endocardium. Using lineage tracing and clonal analysis, our lab 
showed that the endocardium at the AV canal is in fact the source of the 
beginning angiogenic sprouts. After these endothelial cells emerge from the AV 
canal, they first migrate to the bulbus arteriosus and then the angiogenic sprouts 
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continue cover the rest of ventricle as the heart expands. It has been shown by 
other groups that during formation of the lateral aorta and brain capillaries, 
endothelial cells expressing Cxcr4a migrate towards Cxcl12b expressed by the 
endoderm (Bussmann, Wolfe, & Siekmann, 2011; Siekmann, Standley, Fogarty, 
Wolfe, & Lawson, 2009). During our studies we observed strong cxcl12b 
expression in the myocardium before endothelial cells emerge at the AV canal. 
This strong expression in the myocardium is maintained until the vasculature 
network forms, which at that time cxcl12b expression downregulates in the 
myocardium, but upregulates in a cell population located on large coronary 
vessels, which were presumed to be perivascular cells, based on location 
(Harrison et al., 2015). Cxr4a was only expressed after endothelial cells emerge. 
Strong expression of cxr4a was observed on the migratory endothelial cells, but 
was downregulated as the vasculature network formed. In cxcr4a mutant 
zebrafish, the coronary vasculature fails to form and endothelial cells that do 
migrate to the surface appear abnormal and lack coordinated migration. Live 
imaging studies have shown that endothelial cells from cxcr4a mutants lack 
coordinated migration and do not form interconnections with other endothelial cell 
sprouts (Harrison et al., 2015). In addition, cxcl12a/b double mutants did not 
survive past larval stages and did not form vasculature. Cxcr4a-Cxcl12b 
signaling also has a role in regeneration. cxcr4a mutants did not regenerate after 
heart amputation and instead a collagenous scar remained after injury (Harrison 
et al., 2015; Poss et al., 2002). More work remains to determine the exact role of 
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Cxcr4a-Cxcl12 signaling during regeneration. These works suggest a model 
where myocardial expressed Cxcl12b provides migratory cues for endothelial 
cells expressing Cxcr4a, and disruption of this signaling results in lack of 
coronary vasculature during development and reduced regenerative capacity 
after injury. 
Pericytes 
Pericytes were first described over 100 years ago, by Charles-Marie 
Benjamin Rouget, who originally described them as a population of contractile 
cells that surround blood vessel endothelial cells (Armulik 2011). It is now clear 
that there is a variety of different cell types in close proximity to endothelial cells, 
but correct identification can still be problematic (Armulik, Genove, & Betsholtz, 
2011; Krueger & Bechmann, 2010). Contributing to this problem is the fact that 
several molecular markers, complied by different reviews, have also been shown 
to label pericytes and other cell types such as smooth muscle cells. 
Unfortunately, there is not one “universal marker” that can label all pericytes and 
expression of cell markers can be dynamic (Armulik, Abramsson, & Betsholtz, 
2005; Armulik et al., 2011; Diaz-Flores et al., 2009; Krueger & Bechmann, 2010). 
However, several groups have reported Pdgfrb to be a reliable pericyte marker in 
brain micro vessels (Lindahl, Johansson, Leveen, & Betsholtz, 1997; Winkler, 
Bell, & Zlokovic, 2010). Much of what we currently know about pericyte 
morphology was achieved through electron microscopy. Electron microscopy has 
also given us our current accepted definition of a mature pericyte, which is that of 
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a cell that is embedded within the vascular basement membrane (Sims, 1986). 
Pericytes also possess a cell body with a prominent nucleus, and several 
branching processes (Bergers & Song, 2005). Pericytes extend processes that 
run along the surface of the endothelial cells, some of which can span several 
cells. Secondary processes, which branch off primary processes, also extend to 
encircle the endothelial cells (Armulik et al., 2011). As mentioned previously, 
pericytes surround endothelial cells, but how this occurred was unknown. We 
now know that adhesion plaques allow pericytes to attach to endothelial cells, 
while peg-and-socket contacts allow pericytes to penetrate spaces in the 
endothelial cells and achieve a tighter connection between the two cell types 
(Rucker, Wynder, & Thomas, 2000).  
The location of pericytes can vary depending on vessel type. Pericytes 
irregularly cover veins and capillaries, whereas arteries are covered with thick 
layers of smooth muscle cells (Cleaver & Melton, 2003). Pericytes have been 
shown to express smooth-muscle actin, which adds to the confusion on how to 
label cells that are in close proximity to endothelial cells. Current mice models 
suggest during development, cells from the epicardium undergo epithelial-to-
mesenchymal transition (EMT) and migrate deep into the myocardium to form 
epicardium derived cells (EPDC’s), such as fibroblasts, pericytes, and smooth 
muscle cells (Mellgren et al., 2008; Smith, Baek, Sung, & Tallquist, 2011). Since 
pericytes share many characteristics between smooth muscle cells and possibly 
share the same lineage, this had led many people to refer to pericytes as smooth 
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muscle cells, which will explain the interchangeable use in the literature (Bergers 
& Song, 2005). 
Pericyte Function 
Pericytes play a major role in coronary vessel development, and have a 
wide array of functions. Some known roles for pericytes include regulation of the 
vascular diameter, through the act of vasoconstriction or vasodilation (Bergers & 
Song, 2005; Rucker et al., 2000). Pericytes are able to carry out this function, 
due to the fact that they express smooth muscle-like properties. Pericytes also 
play a role in vessel stability and integrity. Mice severely deficient in pericytes 
exhibit vessel hyperdilation and edema formation, both of which contribute to 
embryonic lethality (Lindahl et al., 1997). Part of this response, has to do with 
disruption of a key signaling mechanisms for pericytes, which is Pdgfb/Pdgfrb 
signaling. During vessel development, endothelial cells will secrete factors such 
as PDGF-B, which then recruits pericytes to the newly formed vessels (Betsholtz, 
2004). Once the pericytes attach to the endothelial cells, they can influence 
endothelial differentiation and endothelial cell mitotic rate, by arresting 
endothelial cell growth (Gerhardt & Betsholtz, 2003; K. K. Hirschi, Rohovsky, & 
D'Amore, 1998; Sims, 2000). Researchers have further determined that pericytes 
function to recruit endothelial cells to developing and regenerating vasculature 
(Armulik et al., 2005; Gaengel, Genove, Armulik, & Betsholtz, 2009). Recent 
work suggests that pericytes in the human heart express pdgfrb and 
mesenchymal stem cell markers. These pericytes are able to form capillary 
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networks in culture and more extensive vascular networks when co-cultured with 
endothelial cells (C. W. Chen et al., 2013). In contrast to pericytes sampled from 
skeletal muscle, human heart pericytes increase the angiogenic response during 
hypoxic conditions (C. W. Chen et al., 2013). This data suggests that pericyte 
location can influence pericyte function. 
A recent mouse study suggested that pericytes can also act as 
progenitors for coronary artery smooth muscle cells (Volz et al., 2015).  Using 
Tbx18-Cre lineage tracing and the MADM reporter system, it was revealed that 
pericytes near capillaries are clonally related to coronary artery smooth muscle 
cells (caSMC’s), but retain the function of pericytes (Cai et al., 2008; Volz et al., 
2015; Zong, Espinosa, Su, Muzumdar, & Luo, 2005). Using the NG2-Cre and 
Notch3-Cre lines, pericytes were labeled at a time point where caSMC’s were 
absent (Fre et al., 2011; Zhu et al., 2011). At later time points where caSMC’s 
should be present, they observed caSMC’s were labeled. These two lineage 
tracing experiments strongly suggest that pericyte bridge the gap from 
epicardium to smooth muscle cells, by acting as the intermediate progenitor to 
caSMC’s (Volz et al., 2015). The transition from pericytes to caSMC’s required 
Notch3 signaling, and in Notch3 null mice, pericytes fail to differentiate into 
caSMC’s (Volz et al., 2015). 
PDGF Signaling 
Platelet-derived growth factor (PDGF) was first identified in platelets as a 
mitogenic factor for smooth muscle cells, fibroblasts, and glial cells. Subsequent 
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studies have shown this factor to play a role in responses such as survival, 
migration, and remodeling factors (Bergers & Song, 2005; Betsholtz, Karlsson, & 
Lindahl, 2001; Hoch & Soriano, 2003; Ross, Glomset, Kariya, & Harker, 1974). In 
mice and humans, PDGF’s consist of four ligands (PDGF A-D), and two 
receptors (Pdgfra and Pdgfrb) (Hoch & Soriano, 2003). PDGFRs are receptor 
tyrosine kinases that dimerize upon ligand binding. After ligand binding the 
tyrosine kinase domains activate, which then autophosphorylate several tyrosine 
residues in the receptor cytoplasmic domains (Hoch & Soriano, 2003). The four 
PDGF ligands can bind to either of the two receptors, but PDGF-B preferentially 
binds to Pdgfrb (Bergers & Song, 2005). Our lab has established that zebrafish 
Pdgf-A and Pdgf-B are evolutionary distinct, while phylogenetic studies revealed 
that Pdgf and Pdgfrb proteins were closely related to respective vertebrate 
homologs (Wiens et al., 2010). During mammalian angiogenesis, PDGF-B is 
expressed by sprouting endothelial cells, while Pdgfrb is expressed by pericytes 
(Enge et al., 2002; Hellstrom, Kalen, Lindahl, Abramsson, & Betsholtz, 1999; 
Karen K. Hirschi, Rohovsky, Beck, Smith, & D’Amore, 1999; Lindahl et al., 1997; 
Lindblom et al., 2003; Wiens et al., 2010) 
PDGF/PDGFRB Function in Development and Regeneration 
Our lab has demonstrated disruption of Pdgf signaling has a significant 
effect on zebrafish intersegmental vessel growth (Kim et al., 2010). Chemical 
inhibition of Pdgfr resulted in a significant reduction of complete intersegmental 
vessels at 48 hpf, compared to controls. Using a heat-shock inducible dominant 
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negative Pdgfrb transgenic zebrafish line, our lab observed defective 
intersegmental vessel formation after heat shock (Wiens et al., 2010). These 
results imply PGDF signaling is crucial in vessel development in vivo. A key step 
in the current model of pericyte formation in the heart involves epithelial-to-
mesenchymal transition (EMT) to form epicardial derived cells, some of which 
become pericytes. In zebrafish heart explant cultures, treatment of epicardial 
cells with PDGF-BB induced the epicardial cells to adopt mesenchymal-like 
morphology and reorganization of subcortical actin into stress fibers (Kim et al., 
2010). These are two important hallmarks of EMT in mice models. PDGF 
signaling also plays a role in epicardial cell migration. Mice epicardial knockouts 
of PDGFR exhibited a loss of EPDC’s in the underlying myocardium. 
Mesenchymal marker vimentin and undifferentiated EPDC marker WT1 were 
severely reduced in the epicardial knockouts in the myocardium (Smith et al., 
2011). To support this, other studies have shown that although vimentin is 
severely reduced in the myocardium, it is still expressed in the epicardium at 
E15.5. This suggests that epicardial cells might initiate EMT, but subsequent 
migration is impaired leading to reduced or absent mural cell populations 
(Mellgren et al., 2008). 
 In addition, PDGF signaling also impacts epicardial proliferation in vivo 
during regeneration. Treatment of regenerating zebrafish with PDGFR inhibitor 
resulted in only 14% of epicardial cells proliferating compared to 45% in DMSO 
controls (Kim et al., 2010). These results demonstrate the importance of PDGF 
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signaling in epicardial proliferation. Our lab has also demonstrated the effect of 
disruption of PDGF signaling during heart regeneration. During heart 
regeneration, a key step is the revascularization of the injured area. Our lab has 
demonstrated, that disruption of PDGF signaling results in impaired regeneration 
after injury. Treatment with PDGFR inhibitor resulted in lack of blood vessels in 
the regenerating myocardium, compared to DMSO controls which contained 
blood vessels in the regenerating area (Kim et al., 2010). Mice studies also 
revealed impaired coronary artery development in Pdgfrb mutants. At E14.5, 
Pdgfrb mutant mice possessed abnormal clusters of endothelial cells and no 
dominant vessels formed on the ventral surface. Several studies have 
established the importance of PDGF-B/PDGFRB signaling during vascular 
development. Pdgfrb knockout mice die perinatally and exhibit extensive 
hemorrhaging, and consistent with other studies, vessels lacked or sparsely 
covered by pericytes (Leveen et al., 1994; Soriano, 1994). Also, endothelial 
sprouts are unstable and vulnerable to degradation. (Enge et al., 2002; Hellström 
et al., 2001; Lindahl et al., 1997). 
Pericytes During Zebrafish Cardiac Development 
 Much of what we know from pericyte and coronary vessel development 
comes from murine studies. Whether these findings translate to zebrafish 
remains unclear. Until recently, the origin of zebrafish coronary vessels was 
unknown. In addition, it was not until 2016, that a reliable marker for zebrafish 
pericytes was discovered, although the group did not address if this marker was 
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could be utilized during zebrafish cardiac development. My interest was to 
determine if Pdgfrb can be used as a reliable marker for pericytes during cardiac 
development. In addition, if Pdgfrb labels pericytes, where do these pericytes 
originate from? Another aspect that I wanted to look into was the effect on 
coronary vasculature in the absence of Pdgfrb, by utilizing a previously published 
pdgfrb mutant line. Lastly, could a dominant negative form of Pdgfrb (dnpdgfrb) 
be induced in adult zebrafish, to temporally control Pdgfrb signaling? Confocal 
imaging should allow us to visualize the pericytes during development and by 
taking advantage of the Cre-Lox system, we should be able to do lineage tracing 
studies to determine the origin of cardiac pericytes. Previous research has shown 
that dnpdgfrb induction can be achieved in embryos, so with some possible 
modification it should be possible to achieve induction in adults. 
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CHAPTER TWO 
MATERIALS AND METHODS 
Fish Strain, Care and Treatment 
Zebrafish Strains 
All fish care, maintenance and experimental procedures have been 
approved by CHLA IACUC animal care protocols.  
Tg(fli1a:EGFP)Y1 , Tg(fli1a.ep:DsRedEX)um13 also known as fli1a:DsRed, 
TgBAC(cryaa:EGFP,tcf21:Cre-ERT2)pd42 also known as tcf21:CreERT2, 
TgBAC(tcf21:DsRed2)pd37 , Tg(cxcl12b:YFP), TgBAC(pdgfrb:EGFP), 
TgBAC(pdgfrb:mCitrine), Tg(-3.5ubi:loxP-EGFP-loxP-mCherry) also known as 
ubi:Switch, Tg(gata5:loxP-mCherry-STOP-loxP-nucEGFP)pd40 also known as 
gata5:RnG, pdgfrbum148 (mutant strain), cxcr4aum20 (mutant strain), Tg(-
6.5kdrl:mCherry)ci5, hsp70:Gal4, UAS:dnpdgfrb-yfp 
4-Hydroxytamoxifen (4-OHT) Labeling 
Embryos were treated daily with 4-hydroxytamoxifen (Sigma) from 0-5 
days post fertilization (dpf) in E3 media with a concentration of 10µM, from a 
stock solution of 10mM. Residual 4-OHT was rinsed off the embryos with system 
water before being placed back on the system 
Heat Shock 
Zebrafish were placed in 1L tanks containing 250ml water and heat 
shocked at 38°C for 45 minutes, followed by a 15-minute recovery at room 
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temperature. Following this recovery, the zebrafish were placed back on the 
system to allow for recovery. 
Histology 
Paraffin Embedding 
Tissue was collected from terminally anesthetized fish and fix overnight in 
4% paraformaldehyde (PFA) at 4°C. For subsequent steps, the samples were 
placed on a rocker. DEPC-PBS incubation for 15 minutes, followed by: 30% 
EtOH for 15 minutes, 50% EtOH for 15 minutes, and 70% EtOH for 15 minutes. 
This is followed by 95% EtOH twice for 60 minutes each time, 100% EtOH twice 
for 60 minutes each time, and 100% toluene twice for 60 minutes each time. For 
the subsequent steps, the samples were handled in the core embedding station. 
Samples were placed in 1:1 mix of 100% toluene and 100% paraffin overnight at 
60-62°C. Samples were then incubated in 100% paraffin twice for 60 minutes 
each time. To embed each heart, the heart was placed at the bottom of a steel 
embedding tray containing liquid paraffin. The paraffin block was allowed to 
solidify on ice overnight. Paraffin blocks were stored at 4°C 
Paraffin Sections 
Heart tissue paraffin blocks were sectioned at a 7µm thickness using a 
Leica RM2235 rotary microtome. Sections were placed in DEPC-treated water 
and mounted on glass slides, and dried overnight at 37°C and stored at room 
temperature in a slide box 
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In Situ Hybridization 
This 3-day procedure was performed on zebrafish heart section slides. 
Day 1: 100% toluene for 5 minutes, 100% toluene for 10 minutes, 100% EtOH for 
5 minutes, 80% EtOH for 10 minutes, DEPC-PBST for 5 minutes, 3% H2O2 in 
methanol for 10 minutes, DEPC-PBST for 5 minutes, proteinase K in DEPC-
PBST for 10 minutes, DEPC-PBST for 5 minutes, 4% DEPC-PBS PFA with 0.2% 
glutaraldehyde for 20 minutes, and DEPC-PBST for 5 minutes. Following this, a 
hydrophobic ink pen was used to draw a circle around the tissue. Incubate slides 
in pre-warmed hybridization buffer for 1 hour at 68°C. After incubation, mix probe 
with new hybridization buffer (2µl for every 500ml hybridization buffer) and add 
250ml of this mix to the slides and place a coverslip on each slide. Slides were 
incubated overnight at 70°C.  
Day 2: Remove coverslip and rinse in washing solution for 15 minutes at 
65°C, 30 minutes at 65°C, and 30 minutes at 65°C. Rinse three times in TBSTL 
for five minutes each time. Next, incubate slides for 60 minutes in the embryo 
blocking solution. Dilute anti-DIG antibody 1:1000 in antibody blocking solution. 
Mix the diluted anti-DIG antibody 1:1 in TBSTL containing 1% FBS. Incubate the 
slides for 1 hour in this mixed and diluted anti-DIG antibody solution at room 
temperature. For the color reaction: wash slides in TBSTL for five minutes three 
times, NMTL for five minutes twice, and incubate slides in pre-warmed staining 
solution at 37°C overnight in the dark. 
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Day 3: To stop the color reaction, rinse the slides in tap water for 15 
seconds. Incubate in nuclear fast red counterstain for five minutes, followed by a 
rinse in water until red color disappears from slides. Incubate slides in tap water 
for five minutes. Slides were then incubated in 95% EtOH two times for 1 minute 
each time, and 100% EtOH two times for 1 minute each time. Incubate in 
Citrisolv two times for 1 minute each time. Finally, add 2-3 drops of Cytoseal and 
place coverslip on slide. Slides can be stored at room temperature. 
Imaging 
Whole Mount Confocal Imaging of Heart Tissue 
Zebrafish were anesthetized in tricane for 2 minutes. Hearts were 
removed from terminally anesthetized fish and rinsed for 1 minute in PBS, 
followed by 1 minute in 4% PFA. Hearts were mounted in 1% low melting point 
agarose on a glass-bottom dish. Z-stacks and maximum intensity projections 
were acquired using Zeiss LSM710 and LSM700 confocal microscopes 
Live Imaging 
Hearts were collected from terminally anesthetized 
pdgfrb:EGFP;kdrl:mCherry zebrafish. Hearts were then placed in 5ml of Ringers 
solution containing 100µl/ml Primocin and 150U/ml heparin. The steps above can 
be done outside of a culture hood, but the following steps need to be done inside 
a culture hood. L-15 media (supplemented with 10% FCS, 100µg/ml Primocin, 
1.25mM CaCl2 , and 800mg/l glucose) was added to a glass-bottom dish and 
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hearts were placed at the bottom of the dish towards the middle of the dish. Pre-
cut filter paper was placed on top of the hearts to prevent movement. Z-stack 
images were obtained over the course of 2 days, using a Leica DM IRE2 
microscope. The images were used to form a time-lapse movie. 
Genotyping 
CreERT2 genotyping 
Portion of the caudal fin was amputated and placed in a PCR tube 
containing 50µl of a 50mM NaOH solution. After amputation, fish were kept in 
separate tanks to avoid intermixing. Extraction of DNA was carried out by a 
thermal cycler (Applied Biosystems verity 96 well) by heating sample for 20 
minutes at 95°C. Master mix preparation for 1 sample is as follows, multiplied by 
the number of samples needed: 5µl 5X buffer, 2µl of 25mM MgCl2 , .5µl 10mM 
dNTP’s, .5µl of 20µm Cre S3 forward primer, .5µl of 20µm Cre AS3 reverse 
primer, .2µl GoTaq flexi DNA polymerase (Promega), and 13.3µl distilled water. 
For the PCR reaction each PCR tube contained 23µl of master mix and 2µl DNA. 
PCR program is as follows: 95°C for 5 minutes, 95°C for 30 seconds, 55°C 
(annealing temperature) for 1 minute, 72°C for 1 minute, and 72°C for 7 minutes. 
Reactions were run out on a 1% TAE agarose gel.   
Pdgfrb +/+,+/-,-/- Genotyping 
Pdgfrb +/+,+/-,-/- genotyping protocol the same as the CreERT2 
genotyping protocol, except for the following changes:  
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• Master mix preparation for 1 sample is as follows, multiplied by the 
number of samples needed:  
o 5µl 5X buffer 
o  2µl of 25mM MgCl2 
o  .5µl 10mM dNTP’s  
o .1µl of 100µm pdgfrb tetra WT FWD primer 
o  .1µl of 100µm pdgfrb mut REV primer  
o .1µl of 100µm tetra outer REV primer  
o .1µl of 100µm tetra outer FWD primer 
o  .2µl GoTaq flexi DNA polymerase (Promega)  
o 14.9µl distilled water  
• PCR program was based on the touchdown genotyping method and 
contained 13 stages.  
o Stage 1: 95°C for 1 minute  
o Stage 2: 95°C for 15 seconds followed by 75°C for 1 minute 
o Stage 3: 95°C for 15 seconds followed by 74°C for 1 minute 
o Stage 4: 95°C for 15 seconds followed by 73°C for 1 minute 
o Stage 5: 95°C for 15 seconds followed by 72°C for 1 minute 
o Stage 6: 95°C for 15 seconds followed by 71°C for 30 seconds and 
72°C for 30 seconds 
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o Stage 7: 95°C for 15 seconds followed by 70°C for 30 seconds and 
72°C for 30 seconds 
o Stage 8: 95°C for 15 seconds followed by 69°C for 30 seconds and 
72°C for 30 seconds  
o Stage 9: 95°C for 15 seconds followed by 68°C for 30 seconds and 
72°C for 30 seconds 
o Stage 10: 95°C for 15 seconds followed by 67°C for 30 seconds 
and 72°C for 30 seconds 
o Stage 11: 95°C for 15 seconds followed by 66°C for 30 seconds 
and 72°C for 30 seconds 
o Stage 12: 95°C for 15 seconds followed by 65°C for 30 seconds 
and 72°C for 30 seconds 
o Stage 13: 72°C for 5 minutes. Reactions were run out on a 2% TAE 
agarose gel. 
Cxcr4a +/+,+/-,-/- Genotyping 
Cxcr4a +/+,+/-,-/- genotyping protocol the same as the CreERT2 
genotyping protocol, except for the following changes: for the master mix 
preparation, replace Cre forward and reverse primers with Cxcr4a mFWD and 
Cxcr4a mREV primers. Also reactions were run overnight on a 3% TBE gel, to 
allow for optimal band separation. 
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Pdgfrb;mCitrine Genotyping 
mCitrine genotyping protocol the same as the CreERT2 genotyping 
protocol, except for the following changes: for the master mix, replace forward 
and reverse Cre primers with pdgfrb genotyping FWD and mC/mT/EG FP 5’ REV 
primers. The PCR program is: 95°C for 1 minute, 95°C for 15 seconds, 51°C 
(annealing temperature) for 15 seconds, 72°C for 15 seconds, and 72°C for 7 
minutes. 
Gal4 Genotyping 
Gal4 genotyping protocol the same as the CreERT2 genotyping protocol, 
except for the following changes: for the master mix, replace forward and reverse 
Cre primers with Hsp:gal4 FWD and HSP:gal4 REV. The PCR program is the 
same as CreERT2 genotyping. 
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Table 1. Primer Sequences Used for PCR Genotyping 
 
Stereotyping 
Tcf21:DsRed Stereotyping 
All stereotyping was done using a fluorescent stereoscope. At 4 dpf, red 
fluorescence can be observed as a layer surrounding the ventricle. 
Tcf21:Cre Stereotyping 
At 3-4 dpf, GFP fluorescence can be observed in the lens. 
 
 
Primer Sequence 
pdgfrb genotyping FWD TGT TTC CTT TGG CTT TGA GG 
mC/mT/EG FP 5’ REV GAA CTT CAG GGT CAG CTT GC 
pdgfrb tetra mut REV GGA GGA CGA GTT GAT GGA CAG 
GAT CGT 
pdgfrb tetra WT FWD GAG CTC AGT CCC AGC GCT CCA 
CAG AT 
pdgfrb tetra outer FWD ATA AGT GCA GCT GGA AGG GCG 
TCC TCT G 
pdgfrb tetra outer REV CAC ATA AAC CCC GGT GTG TCT 
CCA GGT C 
cxcr4a mFWD CCA ACT TTG AGG TCC CGT GTG 
cxcr4a mREV TCC AAA CTG ATG AAG GCG AGG 
Cre S3 CGT TTT CTG AGC ATA CCT GGA 
Cre AS3 ATT CTC CCA CCG TCA GTA CG 
HSP: gal4 FWD CGC TAC TCT CCC AAA ACC AAA 
AGG 
HSP: gal4 REV TCT CTT CCG ATG ATG ATG TCG CAC 
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Pdgfrb:mCitrine Stereotyping 
At 5-6 dpf, YFP expression can be found in the jaw region and aortic 
arches. Expression levels can be variable from strong to weak. 
Fli1a:EGFP Stereotyping 
Beginning at 1 dpf, strong GFP expression can be visualized in the 
vessels. Intersegmental vessels running down the trunk are clearly marked. 
Vessel can be seen in head region as well. 
Gata5:RnG Stereotyping 
At 3-4 dpf, strong RFP expression can be observed throughout the entire 
heart. 
Ubi:Switch Stereotyping 
Beginning at 1 dpf, the complete embryo strongly expresses GFP. 
Pdgfrb:EGFP Stereotyping 
From 3-6 dpf, strong GFP expression can be observed in the jaw region, 
aortic arches, and intersegmental vessels. 
Cxcl12b:YFP Stereotyping 
Observable only at early 1 dpf. YFP expression can be observed at the tip 
of the tail, but expression is faint. 
Fli1a:DsRed Stereotyping 
At 4-6 dpf, weak diffused RFP expression can be observed near the aortic 
arches. 
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UAS:dnpdgfrb-yfp Stereotyping  
at 4-6 dpf, strong RFP expression can be observed throughout the whole 
heart. 
Statistical Analysis 
Data was reported as mean ± SEM. Graphs were generated using 
Graphpad Prism software. P values < 0.05 were significant. 
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CHAPTER THREE 
RESULTS 
Pdgfrb Labels Pericytes During Zebrafish Coronary                                
Development 
 
Platelet-derived growth factor (PDGF)-B/PDGF receptor β (PDGFRβ) 
signaling has been shown to be essential in the development of mural cells such 
as vascular smooth muscle cells (vSMC’s) and pericytes, which line and stabilize 
nascent vascular endothelial sprouts (Lindahl 1997; Hellstrom 2001; Leveen 
1994; Karlsson 2000). In addition to the importance of PDGF-B/PDGFR β 
signaling, previous work has also identified Pdgfrb as a reliable marker for mural 
cells (Lindahl 1997;Winkler 2010). Although previous studies have shown the 
origin and fate of pericytes in zebrafish cranial and intersegmental vessel 
development, these studies did not address the development of pericytes in 
coronary vasculature development (Mochizuki, 2016) (Wiens et al., 2010). To 
investigate the role of pericytes in zebrafish coronary vasculature, I crossed 
Tg(flia1:DsRed), a transgenic line which labels endothelial cells, with 
Tg(pdgfrb:mCitrine), which has been previously characterized to label cranial 
vessel pericytes (Vanhollebeke et al 2015). I observed pericyte development 
from early embryonic stages through late-juvenile stages. At the earliest time 
point of observation (Figure 1A), pdgfrb expression is weakly expressed near the 
atrio-ventricular (AV) junction (Figure 1A’), which is a region where endoderm-
derived endothelial cells originate during zebrafish coronary angiogenesis 
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(Harrison et al., 2015). pdgfrb expression at this time point exhibits no obvious 
cellular morphology, but is diffused and non-specific. At 31 dpf, pdgfrb is strongly 
expressed at the AV junction (Figure 1B, insert), but expression can also be 
found at the base of the ventricle and the bulbus arteriosus. As the vasculature 
develops and endothelial cells migrate to cover the ventricle, pdgfrb expression 
exhibits a close and extensive association to the developing vessels (Figure 1C). 
pdgfrb expression starts to adopt a cellular morphology (Figure 1C’, arrow), 
unlike earlier time points. During late-juvenile development, extensive ventricular 
vessel coverage was observed, and pdgfrb+ pericytes are closely associated 
with the vessels (Figure 1D’, arrow). Interestingly, pdgfrb expression during late-
juvenile stage is localized to specific cellular structures on the vessels, and no 
obvious localization of pdgfrb expression can be observed in the atrio-ventricular 
junction. Previous research has noted that pericytes extend processes that can 
span several endothelial cells and even bridge capillaries that are in close 
proximity. Consistent with this, we observed pericytes that are near vessel 
branch points and extend processes that seem to connect neighboring vessels.  
Tcsf21, and Pdgfrb Co-express During Early Coronary 
 Vessel Development  
 
During cardiac development in mice, it has been show that the epicardium 
can undergo EMT and contribute to the pericyte population. Additionally, Pdgfrb 
has been shown to have a close association to the epicardium, but this had not 
been examined in zebrafish previously. To address the epicardial-pdgfrb 
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relationship early in zebrafish coronary development, I utilized the following 
transgenic zebrafish lines which demark the epicardium (tcf21:Dsred) and 
pericytes (Pdgfrb:mCitrine). Consistent with earlier zebrafish findings, the 
epicardium surrounds the ventricle and the atrium (Figure 2A’). Full coverage 
was not achieved, but this can possibly be attributed to differences in expression 
between different transgenic lines. Interestingly, pdgfrb expression seemed to 
closely track the epicardial expression, except for the B.A (Figure 2A’’). Both 
transgenes seem to, at least partially, cover the ventricle and the atrium. On the 
surface of the ventricle and the AV region we can see epicardial cells, which also 
express the pericyte marker Pdgfrb. This seems to support earlier mice findings 
that the epicardium can express pdgfrb during development. My findings seem to 
suggest that early in coronary vessel development, the epicardium expresses 
pdgfrb. One thing I took into consideration is the possible color bleed which could 
affect our results. When comparing the RFP and GFP channel, we can see that 
the bright green expression in the B.A is not mirrored in the B.A of the RFP 
channel. This suggests that our channels are not bleeding into each other and 
validates our imaging. These findings, that the epicardium expresses pdgfrb early 
in cardiac development (30 dpf), give me a good foundation to explore the 
epicardial contribution to the pericyte population observed at coronary vessel 
maturity. Lineage tracing will enable us to better answer these questions in our 
future studies. 
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Cxcl12b+ Cells Express Pericyte Marker Pdgfrb  
Recently, our lab has demonstrated the origin of coronary vessels in 
zebrafish development (Harrison et al, 2015). In contrast to mice, where coronary 
vessels originate from the sinus venosus (Red-Horse et al., 2010), zebrafish 
endothelial cells migrate to the surface from the endocardium near the AV canal. 
This process is directed by Cxcr4a-Cxcl12b signaling, which has been shown to 
have a role in cell migration during development (Boldajipour et al, 2011). The 
angiogenic sprouts that arise from the endocardium express cxcr4a, and are then 
guided to their respective positions by the myocardial secreted ligand Cxcl12b. 
Our lab demonstrated that cxcl12b expression downregulates in cardiomyocytes 
after formation of the vasculature, but is upregulated in perivascular cells that line 
the coronary arteries (Harrison et al, 2015). Unfortunately, we did not have the 
tools at the time to definitively identify these cells as pericytes. To aid in my 
studies, we used a zebrafish line, Tg(pdgfrb:EGFP), that labels pericytes to 
determine if the cxcl12+ perivascular cells are indeed pericytes (Mochizuki, 
2016). I found that cxcl12b-expressing cell coverage was not uniform, but a 
consistent pattern emerged. Along some of the larger coronary vessels, cxcl12b-
expressing cells are in close association with the coronary vasculature (Figure 3 
A-B, arrows). Co-localization of cxcl12b and pdgfrb is mostly seen along the 
major vessels, with very few cells outside of the major vessels. In addition, some 
hearts expressed cxcl12b in the myocardium (Figure 3B, asterisk). Although, 
cxcl12b downregulates in cardiomyocytes after the vasculature forms, it would 
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not be surprising to observe some expression remaining in the myocardium, due 
to the variable nature of coronary vessel formation. Using the line that labels 
pericytes, Tg(pdgfrb:EGFP), I was able to determine that the cxcl12b expressing 
cells previously observed, are indeed pericytes. I was not able to observe 
complete overlap of the two markers, which could indicate that not all cxcl12b 
expressing cells are pericytes, instead probably a subset. 
Lineage Tracing Reveals Epicardial Contribution to the 
Pericyte Population 
 
  Although I established that pericytes reside in close proximity to mature 
coronary vessels, the origin of these pericytes remained unclear. Evidence from 
mouse studies suggests that pericytes are derived from the epicardium, through 
a process of endothelial-to-mesenchymal transition (EMT). I was interested in 
seeing if this was the case for coronary vessel pericytes as well. For our lineage 
tracing experiment, I crossed our pdgfrb:mCitrine line to the tcf21:cre;ubi:switch 
line. Tcf21:Cre is expressed by the epicardium, and ubi:switch is a line that near-
ubiquitously labels all cell types in the zebrafish. Together this combination 
should allow tracking of the descendants of the epicardium though development. 
To ensure maximum labeling efficiency, I treated our embryos from 0-5 dpf with 
10uM 4-OHT (4-Hydroxytamoxifen). My results reveal that some of the 
pdgfrb:mCitrine expressing pericytes co-localize with mcherry (Figure 4B, 
arrows), which indicates the epicardium contributes to cardiac pericytes. 
Interestingly, I also observe pdgfrb:mCitrine expressing pericytes that do not co-
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localize with mcherry (Figure 4B, asterisk). One explanation for this is that 4-OHT 
labeling efficiency was not 100 percent, and it is possible that these pericytes are 
derived from the epicardium, but not labeled due to this lack of 100 percent 
labeling. Another possibility is that these pericytes are not derived from the 
epicardium at all, but rather another cell population, as some recent findings 
have suggested. In addition, we observe mcherry positive cells that do not 
overlap with pdgfrb:mCitrine (Figure 4B, arrowhead). It is possible that these 
descendants of the epicardium are not pericytes, but another cell type such as 
fibroblasts or vascular smooth muscle cells, which would explain why they do not 
express pdgfrb. To support this, mice studies have shown that in addition to 
pericytes, the epicardium can give rise to fibroblasts or vascular smooth muscle 
cells, which could explain our findings. To see if our results were due to 4-OHT 
recombination and not due to “leaky” Cre activity, we looked at our non 4-OHT 
controls. Our controls exhibited no mcherry expression (Figure 4A’’), which 
means that recombination did not occur in the absence of 4-OHT. 
Coronary Vessel Defects Present in Pdgfrb Mutants 
Pericytes are crucial to vessel stability, and studies have shown that 
vessels are vulnerable to degradation in the absence of pericytes, and 
hemorrhaging often results. To investigate any coronary vessel defects in the 
absence of pdgfrb, I used the pdgfrb mutant line with the endothelial cell reporter 
fli1a:EGFP, to track vessel growth. Previous studies in mice have shown that 
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endothelial cells, especially tip cells, secrete Pdgf-B, which then acts as a 
paracrine signal that recruits pdgfrb+ pericytes to the vessels. This pdgfrb mutant 
line has been shown to exhibit extensive hemorrhaging in the head region, but no 
effects were described in heterozygotes. At our early time points (98 dpf), 
heterozygote and mutant hearts displayed similar vessel coverage (Figure 5 A-
B’). Inserts for both groups reveal vessels that have a typical appearance of 
immature vessels (Figure 5 A-B, inserts). What this could suggest is that early in 
development, mutants can form vessels in the absence of pdgfrb, similar to that 
of the heterozygotes. I next asked how vessel development at a later time point, 
where a vessel network should be established, would be affected between the 
two groups? Although it was reported that no effects are exhibited in the 
heterozygotes, coronary vessel development was not addressed. Is it possible 
that heterozygotes and mutants still exhibit abnormal vessel phenotypes at later 
stages, if any? At our last time point (167 dpf), heterozygotes exhibit robust 
coronary vessel coverage compared to sparse coverage of the mutants (Figure 5 
C-D). Vessels on the heterozygote hearts have a normal tube-like structure and 
sprouts interconnect (Figure 5C, insert), whereas the mutant endothelial sprouts 
are very thin in appearance and do not interconnect (Figure 5D, insert). Although 
mutant hearts do not form a coronary vasculature network, I did observe a 
number of endothelial cell “islands” that do not form interconnections (Figure 
5D’). To compare coverage between the two groups at different time points, I 
quantified vessel coverage. When comparing vessel coverage between the 
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heterozygotes and mutants at 98 dpf, I concluded that there was no significant 
difference between them (Figure 5E). When comparing the two groups at 167 
dpf, I found that there was a very significant difference in vessel coverage (Figure 
5F). In mice, studies have shown that disruption in Pdgf/pdgfrb signaling leads to 
unstable vessels and increased susceptibility to degeneration. To support my 
findings, previous work has revealed significant reduction in pericytes leads to 
functionally and structurally abnormal vessels. These findings, along with my 
results, suggest the following as a possible mechanism: pdgfrb mutants might 
form some sort of vessel network early in development, but pdgf/pdgfrb 
disruption between endothelial cells and pericytes, leads to reduced pericyte 
coverage. If the vessels lack pericyte coverage, they can degenerate and lose 
the interconnections, which could explain the “islands” we observed. 
Characterization of Dnpdgfrb Transgenic Zebrafish Line 
To further analyze the question, what happens to the pericyte population 
after Pdgfrb signaling disruption in development and regeneration, I 
characterized a heat-shock inducible dominant negative Pdgfrb (dnpdgfrb) adult 
transgenic zebrafish line. This line, Tg(UAS:dnpdgfrb-
yfp;hsp70:Gal4;fli1a:EGFP), replaces the intracellular tyrosine kinase domain of 
pdgfrb, with YFP. This inactive fusion protein binds to endogenous Pdgfrb and 
prevents auto-phosphorylation (Wiens et al., 2010). The advantages to using this 
dnpdgfrb line is that it gives us the ability to temporally control disruption of 
Pdgfrb signaling as opposed to pdgfrb mutants, which could display cumulative 
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developmental defects. Previously, our lab has demonstrated that after 20 
minutes in 40°C water, strong YFP expression could be observed in embryos, 
and disruption of pdgfrb signaling resulted in impaired intersegmental vessel 
growth. Since my interest is with the pdgfrb+ expressing pericytes, I crossed 
Tg(UAS:dnpdgfrb-yfp;hsp70:Gal4) to Tg(Pdgfrb:EGFP), which labels pericytes 
(Mochizuki, 2016). This will allow us to observe the effects of Pdgfrb signaling 
disruption on the pericyte population. Although our lab utilized this line to analyze 
intersegmental defects in embryos, this line has not been characterized in adult 
zebrafish hearts. To analyze induction in adult hearts, I separated our 
Tg(UAS:dnpdgfrb-yfp;hsp70:Gal4;Pdgfrb:EGFP) zebrafish line into 2 groups, 
non-heat shock and heat shock, which was subjected to 38°C for an hour, for 14 
days. Confocal imaging revealed that the non-heat shocked induced fish 
displayed pericytes but no YFP expression could be observed in the ventricle 
(Figure 6 A-A’’). When looking at the heat shocked induced group, I observed 
pericyte coverage similar to the non-heat shocked group (Figure 6B’). 
Interestingly, I was able to observe strong YFP induction in the heat-shocked 
group, as opposed to the non-heat shocked group (Figure 6 B-B’’). This is the 
first time that dnpdgfrb-YFP induction has been shown in adults using this line. 
This transgenic line will be useful as an alternative to the Pdgfrb mutant line, as it 
will allow us to temporally control Pdgfrb expression. 
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Conclusion 
A crucial aspect of zebrafish heart regeneration is the invasion of blood 
vessels into the damaged area, but the role of pericytes during this process 
remains unclear. By understanding the role of Pdgfrb during development, we will 
better understand the role of pericytes during development. My findings have 
shown that Pdgfrb originates at the AV region of the ventricle and is expressed in 
pericytes near mature vessels. I also demonstrated a strong association of 
Pdgfrb with Tcf21, which suggests a relationship between Pdgfrb and the 
epicardium. With the aid of a Pdgfrb reporter line, I was also able to confirm that 
previously described cxcl12b expressing perivascular cells are a subset 
population of pericytes. Lineage tracing experiments revealed the potential origin 
of the pdgfrb expressing population. My findings revealed that the epicardium 
contributes to the pericyte population at maturity. Further lineage tracing studies 
will help to determine the full extent of the epicardium contribution to populations 
other than pericytes, as shown by my results. Using mutant zebrafish deficient in 
Pdgfrb, I observed that at late stages of development (167 dpf), mutants fail to 
form a proper coronary vasculature network, compared to heterozygote controls. 
The addition of a Pdgfrb transgenic reporter to the mutant line will help to 
elucidate what occurs to the pericyte population in the pdgfrb mutant 
background. Lastly to aid our future regeneration studies, I characterized 
dnpdgfrb, via heat shock induction in adult zebrafish. This line will allow us 
temporal control of the dnpdgfrb domain. Pdgfrb and the pericyte population have 
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been described previously in other organs in zebrafish, but not during coronary 
vessel development. I hope my findings will contribute to more research on this 
topic to help elucidate the mechanism of pericyte contribution in development 
and regeneration. 
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APPENDIX A 
FIGURES 
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Figure 1. Pdgfrb expression in the developing zebrafish heart. At 24 dpf 
(days post fertilization), no endothelial cells are present at the atrio-ventricular 
(AV) canal, but pdgfrb expression can be observed in this region (A-A’). Pdgfrb 
expression at this stage has no obvious cell morphology, but rather diffused in 
appearance. In addition, pdgfrb is strongly expressed in the bulbus arteriosus at 
24-31 dpf, and downregulated at later stages. At 31 dpf, pdgfrb expression 
adopts a more tube like appearance along the AV canal (B-B’), but endothelial 
cells are still not present on the ventricle. At 43 dpf, endothelial cells were 
observed on the surface of the myocardium forming coronary vessel sprouts. At 
this stage pdgfrb expression adopts a cell-like shape and exhibits close 
association with the developing vessels (C-C’, arrow). At my last time point (74 
dpf), the endothelial cells have formed interconnections to form a vast 
vasculature network, while pdgfrb expressing pericytes strongly associate with 
the vessel walls (D-D’, arrow). (V=ventricle, A=atrium, B.A= Bulbus Arteriosus). 
(n=5 for each time point) 
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Figure 2. Overlapping expression of Tcf21 and Pdgfrb during early (30dpf) 
zebrafish coronary development. Merged image of Tcf21:DsRed and 
Pdgfrb:mCitrine expression (A). epicardial expression, as shown by DsRed 
expression, surrounds the ventricle and the atrium, but exhibits reduced 
coverage at the Bulbus Arteriosus (A’). mCitrine expression closely matches 
DsRed expression, except the B.A where mCitrine exhibits intense expression 
not seen with Tcf21 (A’’). (n=4) 
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Figure 3. Cxcl12b positive cells co-express perivascular marker pdgfrb. 
Strong cxcl12b expression is localized to the vessel walls of larger coronary 
vessels (A, arrow). Cxcl12b expressing cells co-localize with the pericyte marker 
pdgfrb (B, arrows). In addition to being expressed by a sub-section of pericytes, 
Cxcl12b expression could also be found in the myocardium surrounding the 
coronary vessels (B, asterisk). No noticeable expression of cxcl12b was 
observed in the pericytes of smaller coronary vessels. (n=5) 
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Figure 4. Tcf21 lineage tracing reveals epicardial contribution to pericytes 
during coronary vessel development. Non 4-OHT group merged images, 
followed by split channel images (A-A’’’). Pericytes could be observed in the BFP 
(mCitrine) channel, but no observable RFP (mcherry) recombination could be 
observed (A’’-A’’’). 4-OHT induced group merged images, followed by split 
channel images (B-B’’’). mcherry expression could be observed in the 4-OHT 
treated group, indicating successful recombination (B’’). Interestingly, mCitrine 
expression co-localizes with a subset of mcherry expression, which suggests that 
the epicardium, at least partially, contributes to the pericyte population (B, 
arrows). In addition, I also found mcherry expression that did not co-localizes 
with mCitrine, which could suggest that the epicardium also contributes to other 
populations besides pericytes (B, arrowhead). (n=5 for 4-OHT, n=4 for Non 4-
OHT) 
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Figure 5. pdgfrb mutants fail to form a coronary vessel network. At our 
earliest time point (98 dpf), pdgfrb heterozygote nascent coronary vessels are 
expanding to cover the ventricle. At this time point, a complete coronary vessel 
network was not observed (A-A’). At this same time point, pdgfrb mutants also 
contain nascent coronary vessels, although vessels appear thinner and flatter in 
shape, not the typical tube structure that has been observed previously (B-B’). At 
our last time point (167 dpf), pdgfrb heterozygotes express a robust coronary 
vasculature that covers the entire ventricle. Small and larger coronary vessels 
can be observed, and the vessels express typical tube like structure (C-C’). At 
the same time point, pdgfrb mutants lack a distinct coronary vasculature. 
Interestingly, isolated endothelial cells are observed on the ventricle, with no 
interconnection between them (D-D’). Quantification of vessel coverage at 98 dpf 
revealed no statistical difference between pdgfrb heterozygotes and mutants 
(n=6 for heterozygotes, n=8 for mutants) (E). Quantification at 167 dpf revealed a 
very significant statistical difference in coronary vessel coverage (n=4 for 
heterozygotes, n=4 for mutants) (F). 
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Figure 6. Heat-Shock induction of dnpdgfrb-YFP. Non-Heat-Shock induced 
fish double transgenic fish (A). GFP channel shows pericytes covering the 
ventricle (A’). YFP signal absent in non-heat shock induced fish (A’’). Heat-Shock 
induced fish double transgenic fish (B). GFP channel shows pericyte coverage 
similar to non-heat shock induced fish (B’). Strong YFP expression can be 
observed in the zebrafish ventricle, compared to non-heat shocked induced fish 
(B’’). H.S= heat shock. (n=5 for Non-H.S, n=6 for H.S) 
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